Innovation

RDT’s innovative QuickStrip™ is an easy-to-use, safe and effective oral fast-dissolving drug delivery system, developed in conjunction with McMaster University through the renowned Adronov Research Group, providing accurate dosing and potency. Aphria Inc. holds the exclusive global preferred rights to license, manufacture, distribute and sell RDT’s QuickStrip™ innovative, proprietary delivery technology for both medical and adult-use cannabis markets.

The Manna cannabis transdermal patch has been developed by pharmaceutical scientists from Massachusetts Institute of Technology using state-of-the-art product design and research methods. It works for all cannabinoids and is designed to work with high-quality, whole-plant cannabis extracts, which are printed on each patch with pharmaceutical quality. Each patch is latex- and allergen-free and delivers the dose automatically through the skin over the course of 12 hours. Aphria Inc. holds a worldwide license agreement to produce and sell the patches containing cannabis oils for its established suite of medical and adult-use brands.

Powered by Aphria Inc.’s best-in-class cannabis production and Perennial’s industry-leading expertise in strategic brand development, this partnership focuses on creating highly differentiated, market-disrupting brands and products that deliver adult-use consumers a unique and targeted cannabis experience.